Representational image | Pixabay
Representational image of a vaccine | Pixabay
Text Size:

Washington: Chinese pharmaceutical maker CanSino Biologics Inc. is in talks with several countries to allow its coronavirus vaccine that’s in development to be used on small groups of people before large-scale safety and effectiveness trials are completed, the Wall Street Journal reported.

The company is speaking to Pakistan, several Latin America countries and some developed nations, the paper said, citing Pierre Morgon, senior vice president for international business at CanSino. Doses could be administered to health-care and other frontline workers if emergency approval is granted, the report said, adding that none have agreed to allow it yet.

The Chinese military has permitted the use of the CanSino vaccine before the completion of large-scale final testing, the report said, citing a company filing.

Tianjin-based CanSino emerged as one of the fastest movers on a vaccine in May, when it became the first firm to publish a full scientific study on its early human trials — a crucial step because it allows researchers to assess a pharmaceutical product’s potential.-Bloomberg


Also read: ‘Deep state’ FDA is taking a beating as review of Covid vaccine approaches


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Share Your Views

LEAVE A REPLY

Please enter your comment!
Please enter your name here